CN116731221B - 一种多糖衍生物及其在制药中的用途 - Google Patents
一种多糖衍生物及其在制药中的用途 Download PDFInfo
- Publication number
- CN116731221B CN116731221B CN202310757085.7A CN202310757085A CN116731221B CN 116731221 B CN116731221 B CN 116731221B CN 202310757085 A CN202310757085 A CN 202310757085A CN 116731221 B CN116731221 B CN 116731221B
- Authority
- CN
- China
- Prior art keywords
- water
- polysaccharide
- demethylated
- soluble soybean
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 163
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 163
- 150000004676 glycans Chemical class 0.000 title claims abstract description 153
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 86
- 244000068988 Glycine max Species 0.000 claims abstract description 84
- 238000002360 preparation method Methods 0.000 claims abstract description 49
- 238000002156 mixing Methods 0.000 claims abstract description 45
- 238000006243 chemical reaction Methods 0.000 claims abstract description 44
- 238000010438 heat treatment Methods 0.000 claims abstract description 35
- 238000001035 drying Methods 0.000 claims abstract description 25
- 230000032050 esterification Effects 0.000 claims abstract description 24
- 238000005886 esterification reaction Methods 0.000 claims abstract description 24
- 230000004048 modification Effects 0.000 claims abstract description 23
- 238000012986 modification Methods 0.000 claims abstract description 23
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 22
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000002244 precipitate Substances 0.000 claims abstract description 22
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims abstract description 20
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940092714 benzenesulfonic acid Drugs 0.000 claims abstract description 19
- 230000029663 wound healing Effects 0.000 claims abstract description 19
- 238000000502 dialysis Methods 0.000 claims abstract description 17
- 230000001737 promoting effect Effects 0.000 claims abstract description 16
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000035755 proliferation Effects 0.000 claims abstract description 9
- 238000003756 stirring Methods 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 6
- 230000007935 neutral effect Effects 0.000 claims abstract description 4
- 238000001816 cooling Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 39
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 39
- 238000006467 substitution reaction Methods 0.000 claims description 24
- 239000006228 supernatant Substances 0.000 claims description 20
- 230000017858 demethylation Effects 0.000 claims description 19
- 238000010520 demethylation reaction Methods 0.000 claims description 19
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 claims description 14
- 230000001376 precipitating effect Effects 0.000 claims description 13
- 230000001105 regulatory effect Effects 0.000 claims description 8
- 239000012295 chemical reaction liquid Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000000052 comparative effect Effects 0.000 description 22
- 239000012153 distilled water Substances 0.000 description 15
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 description 14
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 description 14
- -1 Polysaccharide sulfate Chemical class 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002609 medium Substances 0.000 description 8
- 206010052428 Wound Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000007792 addition Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 230000019635 sulfation Effects 0.000 description 5
- 238000005670 sulfation reaction Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- SWWQQSDRUYSMAR-UHFFFAOYSA-N 1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol;hydrochloride Chemical group Cl.C1=CC(O)=CC=C1CC1C2=CC(O)=C(O)C=C2CCN1 SWWQQSDRUYSMAR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 125000000089 arabinosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
得率(%) | |
实施例1 | 35.79 |
实施例4 | 46.21 |
实施例5 | 36.17 |
实施例6 | 35.48 |
DE(%) | |
实施例1 | 64.2 |
实施例4 | 48.5 |
实施例5 | 59.7 |
实施例6 | 58.4 |
取代度 | |
实施例1 | 1.94 |
实施例2 | 1.97 |
实施例3 | 1.92 |
实施例4 | 2.25 |
实施例5 | 2.02 |
实施例6 | 1.99 |
对比例1 | 1.53 |
对比例2 | 1.25 |
对比例3 | 1.22 |
细胞增值率(%) | |
实施例1-5ng/mL | 63.92 |
实施例1-10ng/mL | 83.71 |
实施例1-20ng/mL | 95.12 |
对比例4-20ng/mL | 17.82 |
对照组 | 11.35 |
时间(d) | 低剂量组伤口愈合率(%) | 中剂量组伤口愈合率(%) | 高剂量组伤口愈合率(%) | 对比例组伤口愈合率(%) | 对照组伤口愈合率(%) |
2 | 7.17 | 8.25 | 8.41 | 6.17 | 6.33 |
4 | 15.28 | 19.31 | 20.18 | 13.49 | 13.19 |
6 | 26.52 | 31.75 | 31.92 | 24.25 | 22.74 |
8 | 40.04 | 52.67 | 53.11 | 35.49 | 35.18 |
10 | 74.63 | 89.47 | 90.13 | 66.82 | 67.92 |
12 | 83.92 | 94.28 | 94.55 | 80.1 | 79.43 |
14 | 91.77 | 96.49 | 96.78 | 83.75 | 83.21 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310757085.7A CN116731221B (zh) | 2023-06-26 | 2023-06-26 | 一种多糖衍生物及其在制药中的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310757085.7A CN116731221B (zh) | 2023-06-26 | 2023-06-26 | 一种多糖衍生物及其在制药中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116731221A CN116731221A (zh) | 2023-09-12 |
CN116731221B true CN116731221B (zh) | 2024-03-12 |
Family
ID=87909560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310757085.7A Active CN116731221B (zh) | 2023-06-26 | 2023-06-26 | 一种多糖衍生物及其在制药中的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116731221B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1651466A (zh) * | 2004-12-31 | 2005-08-10 | 中国药科大学 | 一种多糖的硫酸酯化衍生物及其制法和用途 |
WO2009024026A1 (fr) * | 2007-08-17 | 2009-02-26 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Polysaccharide de gastrodia elata, son dérivé sulfaté et leur préparation et utilisation |
CN101684163A (zh) * | 2008-09-24 | 2010-03-31 | 中国科学院上海药物研究所 | 一种天麻多糖硫酸化衍生物及其制备方法和抗肿瘤用途 |
CN103804508A (zh) * | 2014-03-03 | 2014-05-21 | 河南中烟工业有限责任公司 | 一种烟草多糖硫酸酯的制备方法及其用途 |
CN104479036A (zh) * | 2014-11-26 | 2015-04-01 | 西北工业大学 | 硫酸酯化绞股蓝多糖的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2871379B1 (fr) * | 2004-06-14 | 2006-09-29 | Ifremer | Utilisation de derives polysaccharidiques hautement sulfates et de faible masse molaire pour moduler l'angiogenese |
-
2023
- 2023-06-26 CN CN202310757085.7A patent/CN116731221B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1651466A (zh) * | 2004-12-31 | 2005-08-10 | 中国药科大学 | 一种多糖的硫酸酯化衍生物及其制法和用途 |
WO2009024026A1 (fr) * | 2007-08-17 | 2009-02-26 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Polysaccharide de gastrodia elata, son dérivé sulfaté et leur préparation et utilisation |
CN101684163A (zh) * | 2008-09-24 | 2010-03-31 | 中国科学院上海药物研究所 | 一种天麻多糖硫酸化衍生物及其制备方法和抗肿瘤用途 |
CN103804508A (zh) * | 2014-03-03 | 2014-05-21 | 河南中烟工业有限责任公司 | 一种烟草多糖硫酸酯的制备方法及其用途 |
CN104479036A (zh) * | 2014-11-26 | 2015-04-01 | 西北工业大学 | 硫酸酯化绞股蓝多糖的制备方法 |
Non-Patent Citations (1)
Title |
---|
豆渣多糖硫酸酯化工艺条件优化及其抗氧化活性;王文侠;食品与发酵工业;第39卷(第1期);103-107 * |
Also Published As
Publication number | Publication date |
---|---|
CN116731221A (zh) | 2023-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100528237C (zh) | 多核的氢氧化铁-糖复合物的制备方法 | |
CN101735336B (zh) | 低聚岩藻糖化糖胺聚糖及其制备方法 | |
CN101671373A (zh) | 蔗糖铁原料药及注射液的制备方法 | |
CN106995502B (zh) | 双功能基团改性壳聚糖衍生物及其制备方法 | |
CN107663241B (zh) | 一种高抗性淀粉含量的交联淀粉及其制备方法 | |
CN108498478B (zh) | 一种淀粉基硬胶囊的制备方法 | |
CN103040730A (zh) | 蔗糖铁注射液及其制备方法 | |
CN108424942B (zh) | 一种葡糖基壳核结构的载体材料及其制备与应用 | |
CN105131153A (zh) | 绵羊依诺肝素钠化合物的制备方法及其化合物与应用 | |
CN116731221B (zh) | 一种多糖衍生物及其在制药中的用途 | |
CN105524188B (zh) | 一种透明质酸奇数寡糖单体及其制备方法 | |
CN101475969B (zh) | 木瓜蛋白酶降解壳聚糖的方法 | |
CN107569470B (zh) | 一种萝卜硫素微胶囊的制备方法 | |
CN104877035A (zh) | 一种具有降糖作用的黑木耳多糖的制备方法 | |
US4788307A (en) | Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity | |
CN105860103A (zh) | 一种新型纳米水凝胶的制备方法及其应用 | |
CN111393536B (zh) | 魔芋葡甘聚糖的降解方法 | |
CN106986954A (zh) | 一种达肝素钠和那屈肝素钙联合制备方法 | |
CN108192150B (zh) | 一种增强冷水溶解性且抗消化大米淀粉的生产方法 | |
CN114747668B (zh) | 一种有机复合微量元素及其制备方法 | |
CN103641875B (zh) | 一种多糖铁复合物的制备工艺及其质量检测方法 | |
CN101029094A (zh) | 一种壳聚糖盐酸盐的制备方法 | |
CN101215338A (zh) | 异麦芽低聚糖铁及其制备方法 | |
CN113248633B (zh) | 一种低分子壳聚糖的制备方法 | |
CN102120823B (zh) | 水溶性玉米朊的合成及在药物制剂中的运用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240207 Address after: Building A, 709-D9, International Chamber of Commerce Building, No. 138 Fuhua 1st Road, Fu'an Community, Futian Street, Futian District, Shenzhen City, Guangdong Province, 518031 Applicant after: Yidelai (Shenzhen) Health Technology Co.,Ltd. Country or region after: China Address before: 252 Mayang Community, Chengfeng Town, Yongtai County, Fuzhou City, Fujian Province, 350700 Applicant before: Cheng Xiaolin Country or region before: China |
|
GR01 | Patent grant | ||
GR01 | Patent grant |